Prevalence of treatment-resistant depression in primary care: Cross-sectional data

British Journal of General Practice

Volumn 63, Issue 617, 2013, Pages

  Thomas, Laura ^a   Kessler, David ^a   Campbell, John ^b   Morrison, Jill ^c   Peters, TimJ ^a   Williams, Chris ^c   Lewis, Glyn ^d   Wiles, Nicola ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antidepressants; Prevalence; Primary health care; Treatment resistant depression

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; LOFEPRAMINE; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; REBOXETINE; SERTRALINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION; UNITED KINGDOM; ADOLESCENT; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSIVE DISORDER; DRUG RESISTANCE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; DRUG RESISTANCE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84888801034     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X675430     Document Type: Article

References (25)

1. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H. Psychiatric morbidity among adults living in private households, 2000 (Reprinted from Psychiatric morbidity among adults living in private households, 2000: Summary report, 2001). Int Rev Psych 2003; 15(1-2): 65-73.
2. Health and Social Care Information Centre (Prescribing and Primary Care Services). Prescriptions Dispensed in the Community: Statistics for England - 2001 to 2011. http://www.hscic.gov.uk/catalogue/PUB06941 (accessed 4 Nov 2013).
3. National Services Scotland. Information Services Division. Prescribing & Medicines: Medicines for Mental Health - Financial Years 2002/03 to 2011/12. 2012. https://isdscotland.scot.nhs.uk/Health-Topics/Prescribing-and- Medicines/Publications/2012-09-25/2012-09-25-PrescribingMentalHealth-Report.pdf? 18890017272 (accessed 12 Nov 2013).
4. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006; 354(12): 1243-1252.
5. Berlim MT, Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol 2007; 17(11): 696-707.
6. World Psychiatric Association. Symposium on therapy resistant depression. Pharmacopsychiatry 1974; 7: 69-74.
7. Thase ME, Rush AJ. When at first you don't succeed: Sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997; 58: 23-29.
8. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002; 63(11): 963-971.
9. Ivanova JI, Birnbaum HG, Kidolezi Y, et al. Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Curr Med Res Opin 2010; 26(10): 2475-2484.
10. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiat 2006; 163(11): 1905-1917.
11. Souery D, Oswald P, Massat I, et al. Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. J Clin Psychiatry 2007; 68(7): 1062-1070.
12. Thomas LJ, Abel A, Ridgway N, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: The CoBalT randomised controlled trial protocol. Contemp Clin Trials 2012; 33(2): 312-319.
13. Wiles N, Thomas L, Abel A, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet 2013; 381(9864): 375-384.
14. Beck AT, Steer RA, Brown GK. Beck Depression Inventory Manual - 2nd Edn. San Antonio, TX: The Psychological Corporation, 1996.
15. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1): 67-74.
16. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000; 50(2): 166-171.
17. National Institute for Health and Clinical Excellence (NICE). The treatment and management of depression in adults. Nice Clinical Practice Guideline 90. London: NICE, 2009. http://www.nice.org.uk/nicemedia/pdf/ cg90niceguideline.pdf (accessed 4 Nov 2013).
18. The Health and Social Care Information Centre (Prescribing and Primary Care Services). Prescription Cost Analysis: England 2011. The NHS Information Centre, 2012.
19. DiMatteo M, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Int Med 2000; 160(14): 2101-2107.
20. Carter S, Taylor D, Levenson R. A question of choice - compliance in medicine-taking. A preliminary review. London: Medicines Partnership, 2003.
21. Connolly KR, Thase ME. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 2011; 71(1): 43-64.
22. Stimpson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiat 2002; 181: 284-294.
23. McPherson S, Cairns P, Carlyle J, et al. The effectiveness of psychological treatments for treatment-resistant depression: a systematic review. Acta Psychiatr Scand 2005; 111(5): 331-340.
24. BMA and NHS Employers. Quality and outcomes framework for 2012/13: Guidance for PCOs and practices. 2012. http://www.nhsemployers.org/Aboutus/ Publications/Documents/QOF-2012-13.pdf (accessed 12 Nov 2013).
25. Trivedi MH. Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiat 2009; 70: 26-31.